Enter your email address:

Delivered by FeedBurner

Related Posts Plugin for WordPress, Blogger...

« InterMune Gets Ready To Go Commercial With Esbriet Launch In Europe | Main | NICE Stuns Merck With Demand For Additional Daxas Trial »

August 29, 2011

TrackBack

TrackBack URL for this entry:
http://www.typepad.com/services/trackback/6a00d83452f00669e20153911b9a7c970b

Listed below are links to weblogs that reference Shrinking Funding Rounds For European Biotechs Are No Surprise, But Series A Rounds Look Healthy, If Few:

Search EPT